Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Viewray Inc Cm ST (VRAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 710,735
  • Shares Outstanding, K 75,210
  • Annual Sales, $ 34,040 K
  • Annual Income, $ -72,180 K
  • 36-Month Beta 1.09
  • Price/Sales 21.52
  • Price/Cash Flow N/A
  • Price/Book 19.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.20
  • Number of Estimates 4
  • High Estimate -0.19
  • Low Estimate -0.21
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -5.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.14 +2.74%
on 09/18/18
10.73 -12.49%
on 08/28/18
-0.48 (-4.86%)
since 08/24/18
3-Month
6.63 +41.63%
on 07/02/18
13.21 -28.92%
on 07/25/18
+1.96 (+26.38%)
since 06/25/18
52-Week
5.15 +82.33%
on 09/26/17
13.21 -28.92%
on 07/25/18
+4.01 (+74.54%)
since 09/25/17

Most Recent Stories

More News
ViewRay Announces Equity Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced grants of stock options and...

VRAY : 9.39 (-0.63%)
Acibadem Maslak Hospital in Turkey Introduces Next Generation Cancer Care with MRIdian MR-Image Guided Radiation Therapy

ViewRay, Inc. (Nasdaq: VRAY) announced today that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's MRIdian® Linac, the world's first system to combine MRI guidance...

VRAY : 9.39 (-0.63%)
ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the completion of its previously...

VRAY : 9.39 (-0.63%)
ViewRay Announces Pricing of Public Offering of Common Stock

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the pricing of an underwritten...

VRAY : 9.39 (-0.63%)
ViewRay Announces Proposed Public Offering of Common Stock

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten...

VRAY : 9.39 (-0.63%)
ViewRay Reports Second Quarter 2018 Financial Results

ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2018.

VRAY : 9.39 (-0.63%)
ViewRay, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 3, 2018 / ViewRay, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 3, 2018 at 8:30 AM Eastern Time.

VRAY : 9.39 (-0.63%)
ViewRay Announces Conference Call and Webcast of Second Quarter 2018 Financial Results to be Held Before Market on August 3, 2018

ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2018 financial results, which will take place on Friday, August 3, 2018 before market.

VRAY : 9.39 (-0.63%)
Leading Medical Physics Meeting to Feature More than 50 Presentations on ViewRay's MRIdian MRI-Guided Radiotherapy

ViewRay, Inc. (Nasdaq: VRAY), makers of the world's only FDA-cleared MRI-guided radiation therapy system, announced today that the company's MRIdian® System is the focus of 55 abstracts selected by the...

VRAY : 9.39 (-0.63%)
Free Stock Performance Review on ViewRay and Three Additional Medical Equipment Stocks

Stock Research Monitor: WMGI, ZBH, and ARAY

ZBH : 130.51 (-0.56%)
VRAY : 9.39 (-0.63%)
WMGIZ : 1.40 (+1.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade VRAY with:

Business Summary

ViewRay Inc. is a medical device company. The company develops advanced radiation therapy technology for the treatment of cancer. MRIdian system provides continuous soft-tissue imaging during treatment. ViewRay Inc. is headquartered in Oakwood Village, Ohio.

See More

Key Turning Points

2nd Resistance Point 10.28
1st Resistance Point 9.87
Last Price 9.39
1st Support Level 9.11
2nd Support Level 8.76

See More

52-Week High 13.21
Fibonacci 61.8% 10.13
Last Price 9.39
Fibonacci 50% 9.18
Fibonacci 38.2% 8.23
52-Week Low 5.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar